Apogent Technologies Inc.

Device Transactions Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. ( See Exhibit 1. ) Exhibit 1 Q1 2014 Devic

In this issue, we present another installment of our quarterly review of dealmaking—for January-March 2004. Our data comes from Windhover's Strategic Transactions Database , which covers deal activit

In the past two years, Inverness Medical Innovations has paid roughly a combined $500 million to buy five rapid point-of-care (POCT) diagnostic testing businesses, which now lie at the heart of its

In this issue, we present another installment of our quarterly review of dealmaking—for April-June 2003. Our data comes from Windhover's Strategic Transactions Database , which covers deal activity w